Clincosm LogoSign in Get a demo

malignancies

Showing 1 - 12 of 12
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Glioblastoma, IDH-wildtype, Metformin, Malignancies Trial in Milan (Metformin)

Not yet recruiting
  • Glioblastoma, IDH-wildtype
  • +2 more
  • Milan, Italy
    Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Mil
Jun 26, 2023

Acute Cardiovascular Adverse Events Occuring in Children Treated

Not yet recruiting
  • Malignancies
  • +2 more
  • use of anticancer drugs in monotherapy or in combination therapy
  • (no location specified)
Oct 27, 2022

Malignancies Trial in Worldwide (REGN3767, cemiplimab)

Active, not recruiting
  • Malignancies
  • Encinitas, California
  • +42 more
Aug 25, 2022

Previously Treated, Advanced, Malignancies Trial (TAB006, Toripalimab)

Withdrawn
  • Previously Treated, Advanced
  • Malignancies
  • (no location specified)
May 24, 2022

Malignancies, Stomach Cancer, NSCLC Trial in Jinan (Apatinib)

Completed
  • Malignancies
  • +6 more
  • Jinan, Shandong, China
    (unnamed)
Feb 19, 2018

Malignancies Trial in Ruddington (PWT-143)

Completed
  • Malignancies
  • Ruddington, Nottingham, United Kingdom
    Quotient Clinical
Aug 28, 2017

Vaginal Stenosis With and Without Pelvic Radiation Therapy

Completed
  • Malignancies
  • Stenosis of Vagina
    • Aurora, Colorado
      University of Colorado Hospital
    Apr 27, 2017

    Tumors, Malignancies Trial in Atlanta (Carfilzomib, Dexamethasone)

    Completed
    • Neoplasms
    • Malignancies
    • Atlanta, Georgia
      Emory University Winship Cancer Institute
    Feb 3, 2017

    Malignancies Trial in United States (PWT33597 mesylate)

    Completed
    • Malignancies
    • PWT33597 mesylate
    • Scottsdale, Arizona
    • +3 more
    Oct 23, 2012

    Malignancies Trial in Chicago (satraplatin and capecitabine)

    Terminated
    • Malignancies
    • satraplatin and capecitabine
    • Chicago, Illinois
      Northwestern University Medical Center
    Mar 21, 2012

    Malignancies, B-Cell Lymphoma Trial in Boston, Houston (Aroplatin)

    Completed
    • Malignancies
    • B-Cell Lymphoma
    • Boston, Massachusetts
    • +1 more
    Oct 24, 2008

    Malignancies, Lymphoma Trial in Birmingham (CS-1008 (humanized anti-DR5 antibody))

    Completed
    • Malignancies
    • Lymphoma
    • CS-1008 (humanized anti-DR5 antibody)
    • Birmingham, Alabama
      University of Alabama at Birmingham
    Sep 10, 2007